切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (01): 49 -54. doi: 10.3877/cma.j.issn.2095-3232.2023.01.010

临床研究

超声引导经皮热消融治疗邻近心脏的肝脏恶性肿瘤疗效分析
曾庆劲1, 赵里汶1, 吴宇轩1, 贺需旗1, 张兰霞1, 余萱1, 何娜2, 郑荣琴1, 李凯1,†()   
  1. 1. 510630　广州，中山大学附属第三医院超声科
    2. 514000　梅州，中山大学附属第三医院粤东医院超声科
  • 收稿日期:2022-11-04 出版日期:2023-02-10
  • 通信作者: 李凯
  • 基金资助:
    广州市科技计划项目(201704020164)

Clinical efficacy of ultrasound-guided percutaneous thermal ablation for malignant liver tumors adjacent to the heart

Qingjin Zeng1, Liwen Zhao1, Yuxuan Wu1, Xuqi He1, Lanxia Zhang1, Xuan Yu1, Na He2, Rongqin Zheng1, Kai Li1,†()   

  1. 1. Department of Ultrasound, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    2. Department of Ultrasound, Yuedong Hospital, the Third Affiliated Hospital of Sun Yat-sen University, Meizhou 514000, China
  • Received:2022-11-04 Published:2023-02-10
  • Corresponding author: Kai Li
全文 ( ) 下载PDF ( )
目的

探讨邻近心脏的肝脏恶性肿瘤患者超声引导经皮热消融治疗的疗效及安全性。

方法

回顾性分析2018年6月至2020年12月在中山大学附属第三医院接受热消融治疗的45例邻近心脏的肝脏恶性肿瘤患者临床资料。患者均签署知情同意书，符合医学伦理学规定。其中男35例，女10例；年龄40~80岁，中位年龄60岁；病灶与心脏距离中位数3（1~5）mm；病灶最大直径20（8~64）mm；肝功能Child-Pugh分级A级43例，B级2例；肝细胞癌39例，转移性肝癌6例。观察技术成功率、技术有效率、局部肿瘤进展率、无进展生存期及并发症发生情况。

结果

45例患者共45个病灶，均顺利完成手术，其中采用射频消融31例，微波消融11例，射频联合微波消融3例；采用人工腹水辅助消融10例，人工胸腹水辅助消融1例。围手术期未见明确活动性出血，无肿瘤腹腔种植。术后主要并发症发生率为9%（4/45），其中胆道感染、肝脓肿、窦性心律失常及心力衰竭各1例，经积极干预治疗后好转。消融技术成功率和技术有效率均为100%（45/45）。局部肿瘤进展率7%（3/45），术后中位无进展生存期为10个月，术后3年总体生存率97.7%。

结论

对于邻近心脏的肝脏恶性肿瘤，在合适的手段辅助下，采用超声引导经皮热消融治疗是安全、有效的。

关键词: 肝肿瘤, 超声检查，介入性, 热消融, 射频消融, 微波消融, 治疗结果
Objective

To evaluate the efficacy and safety of ultrasound-guided percutaneous thermal ablation for patients with malignant liver tumors adjacent to the heart.

Methods

Clinical data of 45 patients with malignant liver tumors adjacent to the heart who received thermal ablation in the Third Affiliated Hospital of Sun Yat-sen University from June 2018 to December 2020 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 35 patients were male and 10 female, aged from 40 to 80 years, with a median age of 60 years. The median distance of the lesions to the heart was 3(1-5) mm. The maximum diameter of lesions was 20(8-64) mm. 43 cases were classified as Child-Pugh grade A and 2 cases of Child-Pugh grade B. 39 patients were diagnosed with hepatocellular carcinoma and 6 cases of metastatic liver cancer. The success rate and effective rate of the ablation, local progression rate, progression-free survival and incidence of complications were observed.

Results

45 lesions were detected in 45 patients and the surgeries of all patients were completed successfully. Among them, 31 cases received radiofrequency ablation, 11 cases of microwave ablation and 3 casesof radiofrequency combined with microwave ablation. 10 cases underwent ablation assisted by artificial ascites and 1 case by artificial hydrothorax and ascites. No active bleeding or abdominal tumor implantation was found during the perioperative period. The incidence of major postoperative complications was 9%(4/45), including 1 case of biliary infection, 1 case of liver abscess, 1 case of sinus arrhythmia and 1 case of heart failure, which were mitigated after active interventions. The success rate and effective rate of thermal ablation were both 100%(45/45). The local progression rate was 7%(3/45), the median progression-free survival was 10 months, and the overall 3-year survival rate was 97.7%.

Conclusions

Assisted by appropriate approaches, ultrasound-guided percutaneous thermal ablation is safe and effective for treating malignant liver tumors adjacent to the heart.

Key words: Liver neoplasms, Ultrasonography, interventional, Thermal ablation, Radiofrequency ablation, Microwave ablation, Treatment outcome
图1 一例邻近心脏的肝脏恶性肿瘤患者超声引导经皮热消融治疗 注：a、b为术前增强CT示S2段被膜下病灶原发性肝癌病灶，动脉期呈高增强（a图白色箭头），门静脉期强化减退（b图白色箭头），邻近心脏（b图红色箭头），a为横断面，b为冠状面；c为术中穿刺消融超声造影图像，消融针（红色箭头）首先穿刺消融肿瘤基底部（白色箭头），其后向包膜逐层消融；d为消融术后即时超声造影图像，提示消融灶范围（黄色箭头）覆盖原病灶范围；e、f为消融术后1个月增强CT图像，提示近心脏（红色箭头）病灶热消融范围（黄色箭头）覆盖原病灶（白色箭头）
图2 邻近心脏的肝脏恶性肿瘤热消融术后患者Kaplan-Meier生存曲线 注：a为无进展生存曲线；b为总体生存曲线
表1 射频组和微波组肝癌患者疗效与安全性比较
组别 例数a 年龄[岁，M（Min~Max）] 性别（例，男/女） 病灶直径[mm，M（Min~Max）] 胸腹水辅助（例） 手术时间[min，M（Min~Max）] 术后并发症（例） 技术成功（例） 完全消融（例） LTP（例）
射频组 31 60（40~80） 25/6 20（11~63） 8 70（33~175） 2 31 31 2
微波组 11 52（42~72） 7/4 25（10~64） 2 40（20~97） 2 11 11 1
统计值   Z=0.857 χ2=0.527 Z=-1.217 χ2=0.010 Z=2.988 χ2=0.293 - - χ2=0.000
P值   0.397 0.468 0.231 0.922 0.005 0.589 - - 1.000
表2 胸腹水辅助组与非辅助组肝癌患者疗效与安全性比较
组别 例数 年龄[岁，M（Min~Max）] 性别（例，男/女） 病灶直径[mm，M（Min~Max）] 手术时间[min，M（Min~Max）] 术后并发症（例） 技术成功（例） 完全消融（例） LTP（例）
辅助组 11 71（51~80） 7/4 23（11~63） 95（54~175） 1 11 11 2
非辅助组 34 56（40~74） 28/6 20（8~64） 64（20~160） 3 34 34 4
统计值   Z=3.326 χ2=0.776 Z=1.530 Z=3.150 χ2=0.000 - - χ2=0.001
P值   0.002 0.378 0.133 0.003 1.000 - - 0.973
[1]
Dou J, Cheng Z, Han Z, et al. Microwave ablation vs. surgical resection for treatment naïve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years[J]. Cancer Biol Med, 2021, 19(7):1078-1088.
[2]
Xu XL, Liu XD, Liang M, et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis[J]. Radiology, 2018, 287(2):461-472.
[3]
Viganò L, Laurenzi A, Solbiati L, et al. Open liver resection, laparoscopic liver resection, and percutaneous thermal ablation for patients with solitary small hepatocellular carcinoma (≤30 mm): review of the literature and proposal for a therapeutic strategy[J]. Dig Surg, 2018, 35(4):359-371.
[4]
Izzo F, Granata V, Grassi R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update[J]. Oncologist, 2019, 24(10):e990-1005.
[5]
Tombesi P, Di Vece F, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: what's the first choice?[J]. World J Radiol, 2013, 5(1):1-4.
[6]
European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol,2018, 69(1):182-236.
[7]
Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma[J]. Hepatology, 2018, 67(1): 358-380.
[8]
Vasiniotis Kamarinos N, Sofocleous CT. Imaging and image-guided thermal ablation for oligometastatic colorectal cancer liver disease[J]. Cancer J, 2020, 26(2):124-128.
[9]
Omary RA, Bettmann MA, Cardella JF, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures[J]. J Vasc Interv Radiol, 2002, 13(9 Pt 1):879-881.
[10]
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
[11]
Puijk RS, Ruarus AH, Vroomen L, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION)-a phaseⅢ single-blind prospective randomized controlled trial[J]. BMC Cancer, 2018, 18(1):821.
[12]
Lei P, Ruan Y, Tan L, et al. Laparoscopic colorectal resection combined with simultaneous thermal ablation or surgical resection of liver metastasis: a retrospective comparative study[J]. Int J Hyperthermia, 2020, 37(1):137-143.
[13]
Yang DP, Zhuang BW, Wang YZ, et al. Thermal ablation versus hepatic resection for the treatment of liver metastases from gastrointestinal stromal tumors: a retrospective study[J]. Int J Hyperthermia, 2020, 37(1):592-599.
[14]
Feng Y, Wang L, Lv H, et al. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis[J]. HPB, 2021, 23(4):512-519.
[15]
Kang TW, Rhim H, Lee MW, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy[J]. AJR Am J Roentgenol, 2011, 196(4):907-913.
[16]
Huang Q, Li J, Zeng Q, et al. Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery[J]. BMC Cancer, 2020, 20(1):763.
[17]
Long Y, Zeng Q, He X, et al. One-lung ventilation for percutaneous thermal ablation of liver tumors in the hepatic dome[J]. Int J Hyperthermia, 2020, 37(1):49-54.
[18]
曾庆劲, 李凯, 吴宇轩, 等. 超声引导下经皮非接触式热消融治疗邻近腹壁肝包膜下肝细胞癌[J/CD]. 中华肝脏外科手术学电子杂志, 2019, 8(1):58-62.
[19]
De Muzio F, Cutolo C, Dell'Aversana F, et al. Complications after thermal ablation of hepatocellular carcinoma and liver metastases: imaging findings[J]. Diagnostics, 2022, 12(5):1151.
[20]
Granata V, Fusco R, De Muzio F, et al. Complications risk assessment and imaging findings of thermal ablation treatment in liver cancers: what the radiologist should expect[J]. J Clin Med, 2022, 11(10):2766.
[21]
Poulou LS, Botsa E, Thanou I, et al. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(8):1054-1063.
[22]
Facciorusso A, Abd El Aziz MA, Tartaglia N, et al. Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials[J]. Cancers, 2020, 12(12):3796.
[23]
Han X, Ni JY, Li SL, et al. Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study[J]. Abdom Radiol, 2021, 46(8):3758-3771.
[1] 朱小刚, 阮小燕, 王娟, 邓灵芝, 王志兵, 徐俊涛, 吴乐彬. 超声引导下四肢浅表软组织血肿清除术的应用价值[J]. 中华医学超声杂志（电子版）, 2022, 19(08): 828-831.
[2] 夏凯, 高仁元, 吴小材, 阮瑜, 孙静, 俞明霞, 尹路, 陈春球. 腹腔镜结肠次全切除联合改良Duhamel术治疗成人先天性巨结肠25例报告[J]. 中华普外科手术学杂志(电子版), 2023, 17(01): 91-94.
[3] 胡雄伟, 雷光林, 王森, 宋彪, 洪智贤. Laennec膜入路机器人肝右前叶（S5/8段）切除术[J]. 中华普外科手术学杂志(电子版), 2022, 16(06): 604-604.
[4] 曹李, 牛晓峰, 孟令展, 李虎, 于雁宾, 俞鹏, 严锦, 朱震宇. 同期肝切除联合脾切除在肝癌合并门静脉高压患者中的应用探讨[J]. 中华普外科手术学杂志(电子版), 2022, 16(06): 614-617.
[5] 刘红枝, 刘景丰. 大数据和人工智能在原发性肝癌筛查与诊断中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 1-5.
[6] 丁成明, 侯嘉丰, 陶光伟, 齐硕, 谢翼, 冯灿, 陈振坤, 蒋心渺, 邓鑫, 彭健. 肝细胞癌早期诊断和筛查[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 22-28.
[7] 周毅, 王一帆, 马金良, 余继海, 张传海. ICG荧光影像技术在腹腔镜精准肝段切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 34-38.
[8] 唐啸, 岳志强, 蔡卫华, 陈琳, 居林玲, 袁吉祥, 赵江华, 吴金柱. ICG荧光融合影像技术在肝癌腹腔镜解剖性肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 39-43.
[9] 方诚, 夏勇, 沈锋. 不可切除肝内胆管细胞癌转化治疗策略[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 537-541.
[10] 黄华坤, 杨斌, 张起帆, 邓敬舵, 陈志, 程远. 腹腔镜大肝癌切除术安全性及有效性评估[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 569-573.
[11] 刘文瑛, 欧阳再兴, 朱剑华, 吴黎明, 谭勇, 宋灏, 朱玉珍, 黄从云. 多模态影像技术在精准肝癌肝切除中的应用[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 574-579.
[12] 胡宇, 马金良, 葛勇胜, 余继海, 张传海, 刘文斌, 荚卫东. ICG荧光显像技术在肝癌腹腔镜肝切除术中应用的安全性及疗效[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 580-585.
[13] 邓旭, 韩军伟, 王晶晶, 张灵强, 杨小周, 李钊, 王海久, 樊海宁, 吕明德, 阳丹才让. 超声造影与MRI诊断肝泡型包虫病病灶生物学活性的一致性分析[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 625-628.
[14] 王晶晶, 邓旭, 张灵强, 黄汉生, 王海久, 樊海宁, 王金环, 吕明德, 阳丹才让. 超声造影评估肝泡型包虫病微波消融治疗效果[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 629-633.
[15] 王凯强, 王玉乐, 张灵强, 何少帅, 高颖, 王海久, 樊海宁, 吕明德, 阳丹才让. Em-cfDNA与超声造影对肝泡型包虫病的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 634-638.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号